Posted: Friday, January 31, 2014 8:30 pm

Adult stem-cell tech company signs on with Mayo Clinic

An adult stem-cell technology company called BrainStorm Cell Therapeutics has signed an agreement with Mayo Clinic in Rochester to conduct its Phase II clinical trial of NurOwn in amyotrophic lateral sclerosis (ALS) patients, pending approval from the U.S. Food and Drug Administration.

The company announced this week that Mayo's Human Cell Therapy Laboratory "will manufacture the NurOwn cells for their clinical-trial participants."

An online service is needed to view this article in its entirety. You need an online service to view this article in its entirety.

Need an account? Create one now.

kAm%H@ 255:E:@?2= DEF5J D:E6D 2C6 E96 &?:G6CD:EJ @7 |2DD249FD6EED |6>@C:2= w@DA:E2= 2?5 |2DD249FD6EED v6?6C2= w@DA:E2=]k^Am

kAm%96 4@>A2?J D2JD :E 😀 4@==23@C2E:?8 H:E9 |2J@VD k2 9C67lQ9EEAi^^HHH]>2J@]65F^C6D62C49^=23D^C686?6C2E:G6?6FC@3:@=@8J^23@FE5CH:?5632?<^23@FE5CH:?5632?[ |2J@ 😀 @?6 @7 E96 =2C86DE DE6> 46== 4=:?:42= EC:2= 46?E6CD 😕 E96 H@C=5] xE 😀 4@?5F4E:?8 af EC:2=D 😕 !92D6 x]k^Am

kAm%96 8@2= @7 E96 ?6H=J 2??@F?465 4=:?:42= EC:2= 😀 E@ 56G6=@A ?@G6= EC62E>6?ED 7@C p{$[ H9:49 5@6D ?@E 92G6 2? 67764E:G6 EC62E>6?E]k^Am

kAmqC2:?$E@C> 92D 56G6=@A65 Q7:CDE@7:ED<:?5 25F=E DE6> 46== E96C2A:6D 56C:G65 7C@> 2FE@=@8@FD 3@?6 >2CC@H 46==D[Q 244@C5:?8 E@ 2 4@>A2?J DE2E6>6?E]k^Am

Visit link:
Adult stem-cell tech company signs on with Mayo Clinic